Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
May 04,2016
HIV Particles Used as Tool to Capture Native Protein Complexes
Protein purification has been the cornerstone of laboratory research for decades, and in that time, scientists have funneled considerable effort and finances into isolating protein complexes under native conditions. Classical purification techniques require the use of cell lysis chemicals that often disassociate the interactions between complex protein molecules.   Now Belgian scientists from the FlandersRead more
More
May 03,2016
Different Diseases with Similar Genetic Properties Open New Drug Research Avenues
    The discovery of shared biological properties among independent variants of DNA sequences offers the opportunity to broaden understanding of the biological basis of disease and identify new therapeutic targets, according to the collaboration between the Perelman School of Medicine at the University of Pennsylvania, the University of Arizona Health Sciences, Vanderbilt University, and others. TheRead more
More
May 03,2016
MicroRNA Pathway Could Be New Avenues For Leukemia Treatment
    Increasingly, cancer researchers are discovering novel biological pathways that regulate the expression of various genes that are often strongly associated with tumorigenesis. These new molecular mechanisms represent important potential therapeutic targets for aggressive and difficult-to-treat cancers. In particular, microRNAs (miRNAs)—small, noncoding genetic material that regulates gene expression—have steadily become implicated in the progression of someRead more
More
MicroRNA Pathway Could Be New Avenues For Leukemia Treatment
May 02,2016
Potential Good Fat Biomarker
Brown fat cells can burn fat to generate heat. University of Bonn researchers have discovered a new method to measure the activity of brown fat cells in humans and mice. The researchers showed that microRNA-92a can be used as an indirect measure for the activity of energy consuming brown fat cells. They showed that aRead more
More
May 02,2016
Genomic Study Sheds Light on Evolution of Multicellularity
It's just a clump of 16 cells, but it tells us a lot about an otherwise lost chapter in the evolution of multicellularity. The cells, which belong to a species of green algae called Gonium pectorale, contain genes that clarify how at least one unicellular-to-multicellular transition occurred among a group of closely related organisms, aRead more
More
Genomic Study Sheds Light on Evolution of Multicellularity
Apr 29,2016
Retroviral DNA Findings May Lead to Better Therapies for HIV Infection
    When retroviruses such as HIV infect a cell, they first make a copy of their RNA genome in the form of DNA. The relatively short viral DNA strand then moves to the cell nucleus, where it inserts itself into the host cell’s DNA.     Scientists at The Ohio State University Comprehensive Cancer Center–Arthur G. James CancerRead more
More
Apr 29,2016
New CRISPR System Targets Both DNA and RNA
    With a staggering number of papers published in the past several years involving the characterization and use of the CRISPR/Cas9 gene editing system, it is surprising that researchers are still finding new features of the versatile molecular scissor enzyme.  Researchers from the Max Planck Institute for Infection Biology in Berlin, the Umeå University in SwedenRead more
More
New CRISPR System Targets Both DNA and RNA
Apr 28,2016
Driver of Deadly Brain Cancer Discovered, Potential New Drug Target
Glioblastoma multiforme (GBM) is one of the most common, aggressive, and deadly brain cancers—often difficult to remove surgically and to develop resistance to radiation and chemotherapy. A team of researchers at the University of Ottawa believes they have found a major driving force in tumor formation that could lead to developing novel therapies to treat this intractable cancer.
More
Driver of Deadly Brain Cancer Discovered, Potential New Drug Target
Apr 28,2016
Fusion Protein Technique Shows Promise for Safer Cell Targeted Therapeutics
    A new strategy for engineering protein fusions to make specific cell-targeted drugs without side effects could enable a safer, more potent class of protein drugs, according to scientists at the Wyss Institute for Biologically Inspired Engineering. They say they designed a better variant of the widely used drug erythropoietin (EPO), showing how rational design canRead more
More
Fusion Protein Technique Shows Promise for Safer Cell Targeted Therapeutics
Apr 27,2016
Unique Mouse Model Developed to Study ALS
    Scientists at University of Florida Health say they have developed a unique mouse model that will allow researchers around the world to better study the genetic origins and potential treatments for a neurodegenerative brain disease that causes amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig's disease, and frontotemporal dementia (FTD).     The modelRead more
More
Unique Mouse Model Developed to Study ALS
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->